MentionFox
Home › Crowdfunding › Polaryx Therapeutics, Inc.
Regulation Crowdfunding · SEC Form C

Polaryx Therapeutics, Inc. crowdfunding

Before you invest in Polaryx Therapeutics, Inc.

MentionFox check on Polaryx Therapeutics, Inc.: no red flags found in 5 sources (checked 13 November 2026). mentionfox.com/c/crowdfunding/polaryx-therapeutics

Check Polaryx Therapeutics, Inc. before you invest Free, no sign-up: every record on file, each linked to its source.

What do you want to do about Polaryx Therapeutics, Inc.?

Polaryx Therapeutics, Inc.'s Regulation Crowdfunding offering through Dealmaker Securities LLC: target, maximum, deadline, security, the financials it filed, and every update since, each linked to the SEC filing.

Polaryx Therapeutics, Inc. is raising up to $5M on Dealmaker Securities LLC in common stock at $0.7 each; in its filing revenue was $0 and it had 11 employees (Form C-U, 2025-10-31).

Polaryx Therapeutics, Inc. filed a Regulation Crowdfunding offering with the SEC through Dealmaker Securities LLC, with a target of $15K and a maximum of $5M. As of November 13, 2026, the offering is past its deadline of March 31, 2026. The company gives its address as Paramus, NJ (Form C/A, October 1, 2025).

Sell to companies like Polaryx Therapeutics, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.

Opens in a new tab. No signup.

Key facts

  • · What it is: Progress update · C-U
  • · What it is: Progress update · C-U
  • · Intermediary: Dealmaker Securities LLC · Target: $15K · Maximum: $5M · Deadline: 2026-03-31 · Security: Common Stock · C/A
  • · Intermediary: Dealmaker Securities LLC · Target: $15K · Maximum: $5M · Deadline: 2026-03-31 · Security: Common Stock · C
Target$15K
Maximum$5M
Deadline2026-03-31
Raising throughDealmaker Securities LLC

Polaryx Therapeutics, Inc., based in Paramus, NJ, filed 2 Regulation Crowdfunding offering filings with the SEC, the latest on 2025-10-01, raising through Dealmaker Securities LLC. It set a target of $15K and will accept up to $5M. The security offered is common stock at $0.7 each. As of its filings the offering is past its deadline of 2026-03-31. 4 filings in this family are on record for the company.

Terms at a glance

Target$15K
Maximum it will accept$5M
SecurityCommon Stock
Price per unit$0.7 (0.70)
Units at the target20,704
Raise above the targetaccepted, other
Deadline2026-03-31
Raising throughDealmaker Securities LLC
What the portal is paid, as filedDealMaker will receive an 8.5% cash commission on securities sold in the offering (inclusive of all payment processing, transaction, e-signature and AML fees). There is also a $2,000 monthly platform fee and a $16,500 setup fee payable to DealMaker.

Check before you invest in Polaryx Therapeutics, Inc.: who signed the filing and its own figures, free.

Watch Polaryx Therapeutics, Inc.

Free to see. No signup.

Want the whole picture on Polaryx Therapeutics, Inc.?

Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News

A Full Report on Polaryx Therapeutics, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.

What the Full Report on Polaryx Therapeutics, Inc. covers

  1. The Short Answer

  2. Which Company This Is

  3. What They Do, And How The Money Works

  4. Who Runs It, And How To Reach Them

  5. The Money: Funding, Valuation, Runway

  6. Who Pays Them, And Who They Are Up Against

  7. Warning Bells

  8. Sources

    4 cited sources found

Plus the sections for what you are deciding, which you pick after ordering.

See a sample report

First screen of a real sample Full Report on EchoStar: the verdict, 17 sections, 63 cited sources, built 2026-10-21A real finished report, first screen. Opens in a new tab.

The filing does not state a company valuation or a minimum investment; the offering page on Dealmaker Securities LLC shows those. Check both before you invest.

Offering filings

FiledIntermediaryTargetMaximumDeadlineSecurityFiling
2025-10-01Dealmaker Securities LLC$15K$5M2026-03-31Common StockC/A
2025-09-03Dealmaker Securities LLC$15K$5M2026-03-31Common StockC

Financials the company filed

Figures from the C-U filed 2025-10-31, as the company reported them.

As filedMost recent fiscal yearPrior fiscal year
Revenue$0$0
Net income-$30.36M-$3.78M
Total assets$5M$2.31M
Cash and equivalents$4.62M
Short-term debt$0
Long-term debt$0

Employees at filing: 11.

Revenue went from $0 to $0. Net loss was $30.36M, against a loss of $3.78M the year before. It reported $4.62M in cash and $0 in debt. These are the company's own figures from the Form C-U filed 2025-10-31.

Progress updates

2025-10-31, C-U:

At the close of the offering, the issuer closed on an aggregate of $45,024.70 and 68,756 number of securities.

2025-10-27, C-U:

At the close of the offering, the issuer closed on $23,014.60 and 35,301 number of securities.

People who signed the filing

Every filing

FiledWhat it isFiling
2025-10-31Progress updateC-U
2025-10-27Progress updateC-U
2025-10-01Offering amendedC/A
2025-09-03OfferingC

What to check before investing

Running this raise?

A crowdfunding round is won in public. FoxPlug is your startup's chief of staff: it reads your whole stack and tells you what to say, what to fix and what to skip while the offering is open. Its free tools need no account.

Build your launch kit
Thinking of investing?

Run a Snapshot on Alex Yang: other companies, roles and the record behind them. Order Full Report from there if you need more.

Snapshot the founders

Tools for this story

Each opens in a new tab, filled in for Polaryx Therapeutics, Inc.. With no account yet, you sign up free and land on the result.

Where this comes from

A company raising money from the public under Regulation Crowdfunding has to file with the SEC before the offering opens, and has to raise through a single registered intermediary: a funding portal or a broker-dealer. The first filing, Form C, states how much the company is trying to raise, the most it will accept, the deadline, the security and its price, the intermediary and what the intermediary is paid, and two years of the company's own financial figures.

After that the company files amendments when terms change, progress updates as the raise moves, and an annual report each year until it stops reporting. Every row here is one of those filings, linked to the filing itself, so each figure can be checked at the source. Figures are exactly as the company filed them; where a filing leaves a field blank, so does this page. Nothing here is investment advice, and a filing is the company's own statement, not a verification of it.

More on Polaryx Therapeutics, Inc.

Cite this page

Permanent URL: https://mentionfox.com/crowdfunding/polaryx-therapeutics
Last updated 2026-11-13
Primary record: SEC filing 1 · SEC filing 2 · SEC filing 3 · SEC filing 4
Polaryx Therapeutics, Inc. crowdfunding on Dealmaker Securities LLC: $15K target, up to $5M. MentionFox, 2026-11-13. https://mentionfox.com/crowdfunding/polaryx-therapeutics